Belinda Shipman told Newsweek that the month-long treatment felt like her "face, body and mind were literally being torn ...

Results released April 1, 2026, by the American Society for Radiation Oncology (ASTRO), which represents more than 10,000 ...

A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.